• by Bruce Carlson
  • January 22 2019


Kalorama Expands Analytical and Life Science Instrumentation Research - Introducing Partner Publisher SDi

Kalorama Expands Analytical and Life Science Instrumentation Research - Introducing Partner Publisher SDi

Two well-respected market research brands have joined forces to service life science, diagnostics and analytical instrument customers with accurate market research.  Kalorama Information, leading clinical diagnostics firm, and Strategic Directions International (SDi), a firm with expertise in analytical instrumentation and life sciences equipment, have joined forces as part of Kalorama's recent acquisition by Bioinformatics, Inc., which owns SDi ( as detailed in this press release last year:  https://www.prweb.com/ releases/bioinformatics_inc_ acquires_kalorama_information_ further_solidifying_a_ leadership_position_in_the_ life_science_diagnostics_and_ imaging_markets/prweb15882890. htm ).  Now the two brands have joined forces and established a market research report schedule that will be of benefit to customers. 

 "Through its IBO newsletter, market research reports, and custom research services, SDi provides business intelligence to suppliers of laboratory instrumentation and equipment – everything from pH meters to mass spectrometers," said Mike Tice, Senior Vice President of Business Intelligence for Strategic Directions International. 

 Many business professionals tasked with producing market research are seeing a plethora of numbers on the internet, but are having trouble rectifying those numbers with the pieces of the market they know.  This has increased the emphasis on historic market research brands.  Combined, the two brands have 50 years of experience and a team of skilled analysts.  The brands also have backlists of hundreds of reports and thousands of data points on topics; this year these brands will produce nearly 50 new reports, each one a very detailed and authoritative study of the market in question.  This partnership connects Kalorama with SDi's popular Instrument Business Outlook (IBO) newsletter, which provides thorough coverage of instruments, the life science business, company developments, and market forecasts.

  This means that the publishers of the "Global Assessment Report," covering 50 instrument markets ( https://strategic-directions. com/product/2018-sdi-global- report-life-science- analytical-instrumentation/ ), and the publishers of the "Worldwide Market for In Vitro Diagnostics" ( https://www. kaloramainformation.com/ Worldwide-In-Vitro-Diagnostic- Tests-11th-Edition-11723890/ ) are owned by the same parent company and will share resources and knowledge, to further build on trusted brands. 

 In 2019, the two brands plan reports on:

·       liquid biopsy

·       oil and gas testing,

·       portable mass spectrometry equipment,

·       electron microscopy,

·       infectious disease diagnostics,

·       point-of-care clinical testing,

·       next-generation sequencing (instruments, consumables and sample prep),

·       lab information systems,

·       water testing equipment,

·       food safety diagnostics and regional instrument and diagnostic markets.

 

The two brands will release common catalogs and schedules, covering topics in their strengths. 

 They will also survey instrument buyers and clinical diagnostic buyers and produce reports based on the results.  Both brands will retain their name, report style, and process. 

  Strategic Directions International reports can be found at:  https://strategic-directions. com/


A list of Kalorama Information titles can be found at:  https://www. kaloramainformation.com/

This means that the publishers of the "Global Assessment Report," covering 50 instrument markets, and the publishers of the "Worldwide Market for In Vitro Diagnostics" are owned by the same parent company and will share resources and knowledge, to further build on trusted brands. 

 The two brands join forces along with other Bioinformatics, Inc., publications and the superior radiology market research publications of IMV (these partner publications will be covered in separate articles).  The combination makes sense given the deluge of less-than-reputable market research publishers.  If one needs information on an analytical instrument market, SDi has established reports on that.  For the increasingly clinical migration of some of these instruments, Kalorama will cover that.  It will not be a surprise for most readers to know that for many years, too many market research firms have established, publishing numbers without reasonable due diligence in the marketplace.